Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies

Abstract Background Monthly headache frequency directly correlates with personal/societal burden and impacts severity and preventive treatment decisions. This post hoc analysis identified shifts from higher to lower frequency headache categories over 6 months in patients with migraine participating...

Full description

Bibliographic Details
Main Authors: Patricia Pozo-Rosich, David W. Dodick, Anders Ettrup, Joe Hirman, Roger Cady
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Neurology
Subjects:
Migraine
Prevention
Efficacy
Eptinezumab
Online Access:https://doi.org/10.1186/s12883-022-02914-9

Internet

https://doi.org/10.1186/s12883-022-02914-9

Similar Items